Adam Keane

Improving Patients Lives via Medical Devices

[Adam Keane @AdamKeaneMed]

@stoolgambling Daejon Love… obviously.

[InspireMD @InspireMD]

A new level of stroke prevention is here. CGuard® Prime is now FDA-approved. With over 65,000 stents sold worldwide, we’re ready to elevate embolic prevention for U.S. physicians and their patients.
🔰Ready for a new layer of defense? https://t.co/Jsu2TFbQQj #FDAcleared

[Adam Keane @AdamKeaneMed]

@UMichFootball Good luck and may the best team win! Enjoy the trip, Go Big Red.

[Adam Keane @AdamKeaneMed]

@ALLTHERQ @DropAPinShow @DonnieDoesWorld Whoah, didn’t expect a random stray towards the town I grew up in. 😂

[Adam Keane @AdamKeaneMed]

@zvancam91 @woodyVSworld @PFF Jim Harbaugh is the only NFL coach with a higher win percentage than Matt LaFleur.

[Inquis Medical @Inquismedical]

It’s official! AVENTUS has been FDA cleared to treat pulmonary embolism!

AVENTUS streamlines PE workflows while minimizing blood loss, the first and only thrombectomy system to integrate powerful aspiration, proprietary tissue sensing, and simplified filtered-blood reinfusion. FDA clearance paves the way for new standards in PE intervention, a milestone for Inquis Medical and our physician partners.

Read the full press release: https://t.co/kLYTetdMcE

#FDAcleared #AVENTUS #PulmonaryEmbolism #Thrombectomy #MedicalDevice #InnovationInCare #InquisMedical #Thrombectomy

[Adam Keane @AdamKeaneMed]

@jamespruch Keep the standard helmet, the standard is the standard!

[Adam Keane @AdamKeaneMed]

@NUCLRGOLF @ShipSticks Mini pizzas at the turn like @WaterSoundFL

[Inquis Medical @Inquismedical]

We have fantastic news! What incepted as a mission to transform PE intervention has been substantiated by data!

We are thrilled to share that hashtag#AVENTUS, our novel hashtag#thrombectomy system, designed to simplify VTE treatment and unlock clinical efficiencies, delivered best-in-class pivotal IDE trial results.

The study met its primary safety and efficacy endpoints, demonstrating that AVENTUS significantly reduced RV/LV ratio and clot burden — with short catheter dwell time and zero device related MAEs. Blood was safely and seamlessly returned, resulting in zero blood transfusions. Patient outcomes also benefited, with substantial improvements in functional and quality-of-life measures, as well as brief ICU and hospital stays.

#AVENTUS #PressRelease #PulmonaryEmbolism #Thrombectomy #BloodReinfusion #ClinicalData #MedicalInnovation #PEtreatment

[Adam Keane @AdamKeaneMed]

@StyngrayChosen @BearsPurgatory Butkus and Sayers had a career losing record together and made the playoffs twice in 7 seasons. The legend is greater than the accomplishment.

[Adam Keane @AdamKeaneMed]

@CEssegian @HuskerMBB We believed! Go Big Red!

[Adam Keane @AdamKeaneMed]

@Schrock_And_Awe you forgot to include 15-20 “ums” in this quote.

[Inari, now part of Stryker @InariMedical]

Thank you to the tremendous group of #leaders who made our inaugural Women's Advanced Users Summit such an incredible success! This weekend served to foster the sharing of experience & knowledge among the female physicians advancing the future of #VTE. We are honored to have been joined by this group of like-minded women, and grateful for the opportunity to advance and support #womeninmedicine and those committed to innovation in this space.

[Inari, now part of Stryker @InariMedical]

The importance of clinical evidence in guiding treatment decisions & advancing patient care cannot be overstated.

Dr. Nicole Ilonzo & Dr. Lorena De Marco cover how #ClotTriever became the most studied thrombectomy device in #DVT care on @EVToday https://t.co/PaAps6uYue

[Adam Keane @AdamKeaneMed]

@PFF

[Inari, now part of Stryker @InariMedical]

The #InThrill thrombectomy system is now indicated for AV thrombectomy!

Check out Dr. Alex Misono's recent @CathLabDigest article for tips and tricks on how to efficiently maximize thrombus removal from AV fistulae or AV grafts using #InThrill: https://t.co/CGkL44qjzQ

[Inari, now part of Stryker @InariMedical]

#Protrieve Sheath has received an expanded indication!

Protrieve can now be used as a conduit for the insertion of endovascular devices into the vasculature. This includes the use of compatible #IVC filter retrieval sheaths during #thrombosed IVC filter removal procedures

[Moaaz Elsharabassy @melsharabasssy]

I’m glad to announce that the first case with the novel #flow_saver in the #EMEA region was performed today in our center... a new Era in the treatment of acute PE, not only lytic-free, but also without significant blood loss (today‘s case about 60 ml).

[Toby Richards @TobyRichardsUEL]

Promoting DVT management in Australia hopefully improving access for patients to specialist care& ongoing registry with advance knowledge @RACSurgeons @anzsvs @UWAresearch @ChiefSciWA

[Inari, now part of Stryker @InariMedical]

Presented at #ACC23:

The #FLAME Study reported 1.9% in-hospital mortality in patients treated with #FlowTriever, a >90% reduction compared to the context arm & historical data: https://t.co/zUIlpwjHFU

Register for our upcoming webinar to learn more: https://t.co/taeR9eWW87